News

BIOSIMILAR MEDICINE

“Biological medicines have revolutionised patient treatment by offering new and effective medicines for acute and chronic conditions including neutropenia, cancer, a wide range of inflammatory and autoimmune diseases, and enzyme or hormone deficiencies. As the patent expires for individual originator medicines, biosimilar medicines can be introduced to provide additional options for patients and the NHS.

Biosimilar medicines have been used in the NHS for many years as treatments for growth hormone replacement, neutropenia and anaemia related to chronic renal failure or cancer.

2017 CLLSA Cambridge members Conference Dr Follows video available

The meeting was opened by David Innes as chairman of the CLLSA. This was followed by a presentation by Dr Follows talking about CLL - The disease and its treatment in 2017 and beyond. The afternoon session started with facilitated small group discussions. An opportunity to share tips for coping with CLL and was then followed by three stories from individuals affected by CLL.

 

AbbVie launches first ever series of mindfulness podcasts to support people living with blood cancers

PRESS RELEASE

AbbVie launches first ever series of mindfulness podcasts to support people living with blood cancers

 

  • In collaboration with AbbVie, mindfulness expert Dr Caroline Hoffman has developed a series of new podcast audio recordings specifically tailored to help support people living with blood cancers, and their partners or carers

2016 CLLSA Glasgow Members Meeting

There were 4 medical presentations: two given by
Dr Alison McCraig Affiliate (Paul O'Gorman Leukaemia Research Centre) Glasgow University

as well as presentations by

Dr Emilio Cosimo Research Associate (Paul O'Gorman Leukaemia Research Centre) Glasgow University
Dr Ailsa Holroyd Clinical Research Fellow (Institute of Cancer Sciences) Glasgow University.

The presentations can be found here